Middletown, DE -- (SBWIRE) -- 09/23/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Keryx Biopharmaceuticals (NASDAQ:KERX), New York Mortgage Trust, Inc. (NASDAQ:NYMT), Galena Biopharma Inc (NASDAQ:GALE), Amkor Technology, Inc. (NASDAQ:AMKR).
Keryx Biopharmaceuticals (NASDAQ:KERX) opened its last trade at the price of $9.78. Its closing price was $9.59 after losing -1.94% for the day. The company traded with the total volume of 3.13 million shares, while its average trading volume remained 1.46 million shares. The beta of this stock stands at 3.89. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Has KERX Found The Bottom and Ready To Move Up? Find Out Here
New York Mortgage Trust, Inc. (NASDAQ:NYMT) percentage change surged 2.16% to close at $6.63 with the total traded volume of 2.83 million shares, along with average volume of 972,426.00 shares. The 52 week range of the stock remained $5.51 - $7.69, while its day lowest price was $6.38. The share price hit the day highest price of $6.73. New York Mortgage Trust, Inc., a real estate investment trust (REIT), engages in acquiring, investing in, financing, and managing mortgage-related and financial assets in the United States.
For How Long NYMT’s Gloss will Attract Investors? Find out via this report
Galena Biopharma Inc (NASDAQ:GALE) remained among the day advancers and traded with volume of 2.85 million shares in the last session, as compared to average volume of 2.47 million shares. In comparison with 52 week range of $1.23 - $3.00, it faced lowest price of $1.93 during the last trading session whereas its day highest price was $2.00. The company’s total market capitalization is $168.02 million, along with 84.43 million shares outstanding. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Will GALE Continue To Move Higher? Find Out Here
Amkor Technology, Inc. (NASDAQ:AMKR) started its last trading session with the price of $4.30 and closed at $4.30 by scoring -0.58%. The stock traded with total volume of 2.77 million shares, while the average trading volume remained 822,153.00 shares. The beta value of this stock stands at 2.44. Day range for the stock was $4.26 - $4.36. Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally. The company operates in two segments, Packaging and Test.
Will AMKR Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)